Lung Transplantation under a Janus Kinase Inhibitor in Three Patients with SAVI Syndrome
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lung Transplantation under a Janus Kinase Inhibitor in Three Patients with SAVI Syndrome
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL IMMUNOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-10
DOI
10.1007/s10875-023-01595-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI)
- (2022) Clémence David et al. Cells
- Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database
- (2022) Léa Hoisnard et al. Scientific Reports
- A 17-Year-Old Girl Diagnosed With STING-Associated Vasculopathy With Onset in Infancy (SAVI) After Lung Transplantation
- (2022) Dohyung Kim et al. CHEST
- Severe Liver Disorder Following Liver Transplantation in STING-Associated Vasculopathy with Onset in Infancy
- (2021) Takashi Ishikawa et al. JOURNAL OF CLINICAL IMMUNOLOGY
- STING-Mediated Lung Inflammation and Beyond
- (2021) Marie-Louise Frémond et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype
- (2020) S. L. N. Clarke et al. Pediatric Rheumatology
- Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients
- (2020) Marie-Louise Frémond et al. Journal of Allergy and Clinical Immunology-In Practice
- Évolution et progrès en transplantation pulmonaire : étude de la cohorte de 600 premiers patients transplantés pulmonaires à l’hôpital Foch
- (2019) A. Roux et al. REVUE DES MALADIES RESPIRATOIRES
- STING-associated lung disease in mice relies on T cells but not type I interferon
- (2019) Hella Luksch et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy and Adverse Events During Janus Kinase Inhibitor Treatment of SAVI Syndrome
- (2019) Stefano Volpi et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Hierarchy of clinical manifestations in SAVI N153S and V154M mouse models
- (2019) Mona Motwani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
- (2018) Gina A. Montealegre Sanchez et al. JOURNAL OF CLINICAL INVESTIGATION
- Development of a Validated Interferon Score Using NanoString Technology
- (2018) Hanna Kim et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Severe Pulmonary Fibrosis as the First Manifestation of Interferonopathy (TMEM173 Mutation)
- (2016) Cécile Picard et al. CHEST
- Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173 -activating mutations in 3 children
- (2016) Marie-Louise Frémond et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Copa Syndrome: a Novel Autosomal Dominant Immune Dysregulatory Disease
- (2016) Timothy J. Vece et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Activated STING in a Vascular and Pulmonary Syndrome
- (2014) Yin Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now